Matthew Murawski
About Matthew Murawski
Matthew Murawski is the Director of Global Alliances, Strategy, and Business Development at Bristol Myers Squibb in Cambridge, Massachusetts, with a strong background in immunology and virology.
Current Role at Bristol Myers Squibb
Matthew Murawski serves as the Director of Global Alliances, Strategy, and Business Development at Bristol Myers Squibb. He is currently based in Cambridge, Massachusetts. In this role, he focuses on developing and managing strategic alliances and business initiatives that align with the company's objectives.
Previous Roles and Experience
Matthew Murawski's career includes significant roles in various companies, predominantly in the biopharmaceutical sector. He worked at STEMCELL Technologies, initially as Senior Manager of Primary and Cultured Cells and later as Associate Director of Human Primary & Cultured Cells. Prior to this, he served as Senior Director of Business Development at ApoCell Inc. and as Director of Business Development at Asterand. His early career included technical sales and lab-based roles at Wyeth Pharmaceuticals and Stemcell Technologies Inc., as well as a postdoctoral fellowship at Harvard Medical School.
Educational Background
Matthew Murawski holds an Executive MBA from Questrom School of Business, Boston University. He earned a Ph.D. in Biomedical Sciences, focusing on Immunology and Virology, from UMass Chan Medical School. His academic journey began with a B.A. in Biology from St. Anselm College, followed by further studies in Biomedical Sciences at the University of Florida.
Research and Publications
Matthew Murawski boasts a strong background in immunology and virology, evidenced by his Ph.D. and significant publication record in high-impact scientific journals. He frequently presents his findings at national and international research conferences. His research interests extend to building cell and gene therapy tools aimed at advancing drug discovery.
Expertise in Drug Discovery
Murawski has extensive experience in assisting biopharmaceutical customers with the development of pre- and early-stage clinical drug candidates and companion diagnostics. Known for managing multiple projects simultaneously, he consistently delivers high-quality results. His passion lies in creating enabling tools for cell and gene therapy research, making a notable impact in the field of drug discovery.